Vulnerability in Philips Clinical Collaboration Platform
CVE-2020-16247
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.8 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H.
EPSS exploit prediction
EPSS: 0.004 (28.8th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 29th percentile — 28.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000
Affected products
Weakness classification (CWE)
References
- us-cert.cisa.gov/ics/advisories/icsma-20-261-01 (US Government Resource, Third Party Advisory)
- www.philips.com/a-w/security/security-advisories/product-security-2020.html
Frequently asked questions
- What is CVE-2020-16247?
- CVE-2020-16247 is a medium-severity vulnerability in Philips Clinical Collaboration Platform, classified under CWE-16. CVSS score: 6.8/10. Published 2020-09-18.
- How severe is CVE-2020-16247?
- Medium severity. CVSS v3 base score is 6.8 out of 10.